Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir

Título

Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir

Autor

Hao Song, Yu Bai, Fei Ye, Yong Feng, Hanyi Liao, Jianxun Qi, George Fu Gao, Wenjie Tan, Lifeng Fu, Yi Shi

Fecha

2021

Identificador

10.1038/s41392-021-00468-9

Fuente

Epidemiology and Health

Editor

Korean Society of Epidemiology

Cobertura

Biology (General), Medicine

Archivos

https://socictopen.socict.org/files/to_import/pdfs/30d9d57e47fe0382b53f73e27872690d.pdf

Colección

Citación

Hao Song, Yu Bai, Fei Ye, Yong Feng, Hanyi Liao, Jianxun Qi, George Fu Gao, Wenjie Tan, Lifeng Fu, Yi Shi, “Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir,” SOCICT Open, consulta 18 de abril de 2026, https://www.socictopen.socict.org/items/show/8567.

Formatos de Salida

Position: 3625 (40 views)